Showing 171-180 of 3058 results for "".
Reversible and Benign Lesions of Splenium of The Corpus Collosum
https://practicalneurology.com/diseases-diagnoses/imaging-testing/reversible-and-benign-lesions-of-splenium-of-the-corpus-collosum/30269/Aggressive diagnostic and therapeutic approaches are often unnecessary.The Immune Stroke Spectrum: Navigating Inflammatory Cerebrovascular Disorders
https://practicalneurology.com/diseases-diagnoses/stroke/the-immune-stroke-spectrum-navigating-inflammatory-cerebrovascular-disorders/49163/This review provides a concise overview of commonly encountered inflammatory cerebrovascular disorders, highlighting their clinical features, diagnostic challenges, and treatment strategies, and emphasizing that despite their complexity, early recognition and systematic management often lead to fClinical Use of Dementia Biomarkers to Evaluate Cognitive Deficits in People With Primary Psychiatric Disorders
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/clinical-use-of-dementia-biomarkers-to-evaluate-cognitive-deficits-in-people-with-primary-psychiatric-disorders/32101/Biomarkers may assist in identifying whether symptoms are the result of the primary psychiatric process or a neurodegenerative process.Vascular Cognitive Impairment, Part 2
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/vascular-cognitive-impairment-part-2/30582/Cognitive impairment after acute stroke is likely under-appreciated despite its impact.Emerging Treatments for Tardive Syndrome
https://practicalneurology.com/diseases-diagnoses/movement-disorders/emerging-treatments-for-tardive-syndrome/32042/Practical approaches and emerging treatments offer novel therapeutic strategies for tardive syndrome.MELAS: A Tricky Disease with an Easy Diagnostic Test
https://practicalneurology.com/diseases-diagnoses/stroke/melas-a-tricky-disease-with-an-easy-diagnostic-test/30638/MELAS (mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes) is a multisystem disorder with onset typically in childhood. Mutation in mitochondrial DNA gene MT-TL1 is cause of the disease in 80 percent.Two Steps Can Reduce the Incidence of Secondary Stroke
https://practicalneurology.com/diseases-diagnoses/stroke/two-steps-can-reduce-the-incidence-of-secondary-stroke/30574/Stroke is a leading cause of death and disability in the US with over 800,000 cases per year, but there are steps that can improve outcomes.Dystonia Treatment: Current Approach and Future Directions
https://practicalneurology.com/diseases-diagnoses/movement-disorders/dystonia-treatment-current-approach-and-future-directions/32168/The management of dystonia requires a multifacted approach designed to alleviate symptoms, improve functional capacity, and enhance overall quality of life.Etiology and Treatment of Urogenital Dysfunction in Individuals with Parkinson Disease
https://practicalneurology.com/diseases-diagnoses/movement-disorders/etiology-and-treatment-of-urogenital-dysfunction-in-individuals-with-parkinson-disease/37653/Urogenital dysfunction is a common nonmotor symptom observed in people with Parkinson disease which can negatively impact quality of life, necessitating careful investigation and prompt treatment.Medical Marijuana and Movement Disorders
https://practicalneurology.com/diseases-diagnoses/movement-disorders/medical-marijuana-and-movement-disorders/31951/Medical marijuana can be a useful tool for addressing nonmotor symptoms of movement disorders.